Serina Therapeutics Stock Probability of Future Stock Price Finishing Over 32.67
| SER Stock | 5.64 0.36 6.82% |
Serina |
Serina Therapeutics Target Price Odds to finish over 32.67
The tendency of Serina Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 32.67 or more in 90 days |
| 5.64 | 90 days | 32.67 | close to zero percent |
Based on a normal probability distribution, the odds of Serina Therapeutics to move over 32.67 or more in 90 days from now is close to zero percent (This Serina Therapeutics probability density function shows the probability of Serina Stock to fall within a particular range of prices over 90 days) . Probability of Serina Therapeutics price to stay between its current price of 5.64 and 32.67 at the end of the 90-day period is about 62.58 .
Considering the 90-day investment horizon Serina Therapeutics has a beta of -1.97. This usually implies as returns on its benchmark rise, returns on holding Serina Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Serina Therapeutics is expected to outperform its benchmark. Additionally Serina Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Serina Therapeutics Price Density |
| Price |
Predictive Modules for Serina Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Serina Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Serina Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Serina Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Serina Therapeutics is not an exception. The market had few large corrections towards the Serina Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Serina Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Serina Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | -1.97 | |
σ | Overall volatility | 1.06 | |
Ir | Information ratio | -0.02 |
Serina Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Serina Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Serina Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Serina Therapeutics generated a negative expected return over the last 90 days | |
| Serina Therapeutics has high historical volatility and very poor performance | |
| Serina Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Serina Therapeutics was previously known as AgeX Therapeutics and was traded on NYSE MKT Exchange under the symbol AGE. | |
| The company reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 0. | |
| Serina Therapeutics generates negative cash flow from operations | |
| Serina Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 58.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from nypost.com: Babygirl director defends age gap in Nicole Kidman erotic thriller It should completely be normalized |
Serina Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Serina Stock often depends not only on the future outlook of the current and potential Serina Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Serina Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 345 K |
Serina Therapeutics Technical Analysis
Serina Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Serina Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Serina Therapeutics. In general, you should focus on analyzing Serina Stock price patterns and their correlations with different microeconomic environments and drivers.
Serina Therapeutics Predictive Forecast Models
Serina Therapeutics' time-series forecasting models is one of many Serina Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Serina Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Serina Therapeutics
Checking the ongoing alerts about Serina Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Serina Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Serina Therapeutics generated a negative expected return over the last 90 days | |
| Serina Therapeutics has high historical volatility and very poor performance | |
| Serina Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Serina Therapeutics was previously known as AgeX Therapeutics and was traded on NYSE MKT Exchange under the symbol AGE. | |
| The company reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 0. | |
| Serina Therapeutics generates negative cash flow from operations | |
| Serina Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 58.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from nypost.com: Babygirl director defends age gap in Nicole Kidman erotic thriller It should completely be normalized |
Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.